Suven Life Sciences Limited Stock NSE India S.E.
Equities
SUVEN
INE495B01038
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
114.6 INR | +1.87% | +4.14% | +41.86% |
Sales 2022 | 120M 1.43M | Sales 2023 | 136M 1.63M | Capitalization | 10.57B 127M |
---|---|---|---|---|---|
Net income 2022 | -1.22B -14.65M | Net income 2023 | -1.18B -14.2M | EV / Sales 2022 | 109 x |
Net cash position 2022 | 472M 5.67M | Net cash position 2023 | 2.27B 27.23M | EV / Sales 2023 | 61.1 x |
P/E ratio 2022 |
-9.69
x | P/E ratio 2023 |
-7.31
x | Employees | 132 |
Yield 2022 |
1.08% | Yield 2023 |
-
| Free-Float | 28.95% |
Latest transcript on Suven Life Sciences Limited
1 day | +1.87% | ||
1 week | +4.14% | ||
Current month | +14.55% | ||
1 month | +16.95% | ||
3 months | +5.48% | ||
6 months | +79.12% | ||
Current year | +41.86% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 89-03-08 | |
M. Mohan Kumar
DFI | Director of Finance/CFO | - | 20-01-09 |
Shrenik Soni
CMP | Compliance Officer | - | 20-01-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 89-03-08 | |
Sudha Rani Jasti
FOU | Founder | 70 | 89-03-08 |
Director/Board Member | 70 | 10-04-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 114.6 | +1.87% | 476 695 |
24-04-24 | 112.4 | +5.00% | 236,641 |
24-04-23 | 107.1 | +2.93% | 480,657 |
24-04-22 | 104 | -1.98% | 246,614 |
24-04-19 | 106.2 | -3.50% | 296,114 |
Delayed Quote NSE India S.E., April 25, 2024 at 05:19 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+46.85% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- SUVEN Stock
- SUVEN Stock